London, UK (PRWEB) February 13, 2014
In the recent past, the level of automation in the microbiology laboratory has been falling behind that of other key clinical laboratory sectors, like hematology and chemistry. The sluggish rate of technological adoption is in part due to the complications with developing automation suited for carrying out microbiology tests. A number of technical and intrinsic issues have postponed the introduction of automated microbiology instrumentation. Alongside the effects of different reimbursement plans, there have been several less easily discernable factors that have adversely impacted the rate of microbiology automation acquisition. Nevertheless, more progressive automated instrumentation is anticipated to come into existence in the microbiology universe in the offing.
The driving factor lying behind the necessity of rapid reporting of the results of microbiological tests is the clinical relevance in the days of financial austerity measures, when heathcare costs and effectiveness loom larger for both diagnosticians and patients, and where after-the-fact results at high expense are coming under close scrutiny from pole to pole.
Myriad Genetics, Becton Dickinson, Eiken Chemical, Ortho-Clinical Diagnostics, Novartis Diagnostics/Grifols, Takara Bio, Sierra Molecular, Agilent Technologies, Monogram Biosciences, Proteome Sciences, Abbott, Roche, Exact Sciences and Beckman Coulter/Danaher are among the companies holding leadership positions in the world automated microbiology market.
New research report “2014 Automated Microbiology Market-- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics” worked out by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.
Title: 2014 Automated Microbiology Market-- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
Published: February, 2013
Price: US$ 34,500.00
The comprehensive report is an essential source of accurate information on the performance of the world automated microbiology market. It provides an extensive analysis of the current market scenario with a focus on the seven country markets (the US, France, Germany, Spain, Italy, the UK and Japan), sheds light on the opportunities emerging in the automated microbiology market space, and features current and emerging assays. The topical study presents a snapshot of the potential applications of novel innovative diagnostic technologies, characterizes the competitive climate and profiles both the entrenched market players and new market entrants, as well as uncovers details on the alternative business expansion strategies. The report contains historical, present and forecast test volume and sales statistics for more than 100 infectious diseases; identifies the key factors influencing the market dynamics, scrutinizes the industry structure and includes an extensive summary of the currently available products. Additionally, the world automated microbiology market future outlook is at hand.
Reasons to Buy:
- Gain a complete understanding of the current scenario in the seven major country markets for automated microbiology.
- Expand your company share in the world automated microbiology market by taking informed business decisions.
- Identify, evaluate and exploit the emerging market opportunities.
- Develop effective business strategies by getting profound insights into the market landscape.
- Receive valuable strategic recommendations.
- Get acquainted with the currently available products in the marketplace and obtain access to test volume and sales statistics.
- Review the alternative market penetration strategies.
- Get ready to cope with the potential market barriers and challenges.
- Foresee how the global automated microbiology market is likely to develop in the upcoming years.
More new research reports by the publisher can be found at VPG page.